Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8

Open access

Abstract

Significance: Oligodendrocyte precursor cells (OPCs) constitute the main proliferative cells in the adult brain and deregulation of OPC proliferation-differentiation balance results in either glioma formation or defective (re)myelination. Mutations in chromatin remodelers CHD7 and CHD8 are the cause of CHARGE syndrome and some autism spectrum disorders (ASD). Here we show that Chd7 protects OPCs from apoptosis by chromatin closing and gene repression of p53 , while Chd7 induces chromatin opening and gene activation of OPC-differentiation regulators. Chd7 is, however, dispensable for oligodendrocyte stage progression, consistent with Chd8 compensatory function, as suggested by their common chromatin-binding profiles, including ASD-risk–associated genes. Our results thus involve oligodendroglia in ASD and CHARGE and offer new avenues to understand and modulate CHD7/CHD8 functions in normal and pathological brain development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1802620115

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Chd7 bind to genes involved in OPCs proliferation, differentiation, and survival. (A and B) Immunostaining of Chd7 with PDGFRα and CC1 (A) or Olig1 and CC1 (B) in the CC of P24 mice. Gray arrowheads show OPCs and gray arrows show OLs. (Scale bar, 10 μm.) (C) Scheme representing expression levels of different markers depending on OL stage. (D) Diagram representing MACSorting of O4+ cells of P7 wild-type mice followed by Chd7 ChIP-seq. (E and F) Venn diagrams depicting the overlap of Chd7-binding sites (E) and bound genes (F) in OPCs and OLs, with examples of genes involved in OPC differentiation (blue), cell death (orange), and cell cycle (red). (G) Barplot representing the GO analysis of the OPC- or OL-only Chd7-bound genes. (H) Representative ChIP-seq tracks for Chd7 and control IgG together with active epigenetic marks (H3K27ac and H3K4me3) of Trp53, Ccnd1, and Sox10 genes in OPCs and OLs. (I and J) Graph showing the number of correlations of Chd7 peaks in OPCs (blue) and OLs (black) compared with the position in enhancer regions (I) and promoter regions (J).
Fig. 1. Chd7 bind to genes involved in OPCs proliferation, differentiation, and survival. (A and B) Immunostaining of Chd7 with PDGFRα and CC1 (A) or Olig1 and CC1 (B) in the CC of P24 mice. Gray arrowheads show OPCs and gray arrows show OLs. (Scale bar, 10 μm.) (C) Scheme representing expression levels of different markers depending on OL stage. (D) Diagram representing MACSorting of O4+ cells of P7 wild-type mice followed by Chd7 ChIP-seq. (E and F) Venn diagrams depicting the overlap of Chd7-binding sites (E) and bound genes (F) in OPCs and OLs, with examples of genes involved in OPC differentiation (blue), cell death (orange), and cell cycle (red). (G) Barplot representing the GO analysis of the OPC- or OL-only Chd7-bound genes. (H) Representative ChIP-seq tracks for Chd7 and control IgG together with active epigenetic marks (H3K27ac and H3K4me3) of Trp53, Ccnd1, and Sox10 genes in OPCs and OLs. (I and J) Graph showing the number of correlations of Chd7 peaks in OPCs (blue) and OLs (black) compared with the position in enhancer regions (I) and promoter regions (J).CC BY-NC-ND · PubMed Central
Fig. 2. Chd7-regulated genes involved in OPCs proliferation, differentiation, and survival. (A) Diagram representing tamoxifen (Tam) administration to control (Ctrl) and Chd7iKO (iKO) mice at P1 and P4 followed by MACS-sorting of O4+ cells at P7. Cells are then used for either RNA-seq or ATAC-seq. (B) Immunostaining of P7 brain sections showing that all PDGFRα+ OPCs express Chd7 in the CC of Ctrl mice, while only a few OPCs maintain Chd7 expression in iKO mice. Star shows a Chd7-expressing OPC in iKO. (Scale bars, 10 μm.) (C) Quantification of Chd7+ OPCs as a percentage of total PDGFRα+ cells in the CC and cortex (Ctx) of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 5). Exact P values can be found in Dataset S2. ***P < 0.001. (D) Pie chart showing the relative percentage and number of genes that were significantly up-regulated or down-regulated in P7 iKO O4+ cells compared with Ctrl (fold-change > 1.2; P < 0.05). (E) GO analysis of the up-regulated (red) and down-regulated (blue) genes in Chd7iKO cells compared with Ctrl. Numbers indicate the number of genes of each category. (F) Heatmap representing the expression of 100 most different genes in Ctrl and iKO O4+ cells (n = 7 Ctrl and 5 iKO). (G) Venn diagram depicting the overlap of Chd7-binding genes in OPCs with down-regulated (blue) or up-regulated (red) genes in iKO cells with examples of Chd7-bound genes involved in OL differentiation (blue), cell death (orange), and cell cycle (red).
Fig. 2. Chd7-regulated genes involved in OPCs proliferation, differentiation, and survival. (A) Diagram representing tamoxifen (Tam) administration to control (Ctrl) and Chd7iKO (iKO) mice at P1 and P4 followed by MACS-sorting of O4+ cells at P7. Cells are then used for either RNA-seq or ATAC-seq. (B) Immunostaining of P7 brain sections showing that all PDGFRα+ OPCs express Chd7 in the CC of Ctrl mice, while only a few OPCs maintain Chd7 expression in iKO mice. Star shows a Chd7-expressing OPC in iKO. (Scale bars, 10 μm.) (C) Quantification of Chd7+ OPCs as a percentage of total PDGFRα+ cells in the CC and cortex (Ctx) of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 5). Exact P values can be found in Dataset S2. ***P < 0.001. (D) Pie chart showing the relative percentage and number of genes that were significantly up-regulated or down-regulated in P7 iKO O4+ cells compared with Ctrl (fold-change > 1.2; P < 0.05). (E) GO analysis of the up-regulated (red) and down-regulated (blue) genes in Chd7iKO cells compared with Ctrl. Numbers indicate the number of genes of each category. (F) Heatmap representing the expression of 100 most different genes in Ctrl and iKO O4+ cells (n = 7 Ctrl and 5 iKO). (G) Venn diagram depicting the overlap of Chd7-binding genes in OPCs with down-regulated (blue) or up-regulated (red) genes in iKO cells with examples of Chd7-bound genes involved in OL differentiation (blue), cell death (orange), and cell cycle (red).CC BY-NC-ND · PubMed Central
Fig. 3. Chd8 binds together with Chd7 to OPC differentiation, proliferation, and survival genes. (A) Chd8 immunolabeling of P14 brain sections showing Chd8 expression in all maturing OLs (CC1high-expressing cells, arrows) of the CC, as well as in neurons of the cortex (Ctx). (A1) Detail of the Inset in A showing that, beside the high Chd8 expression in maturing OLs (white arrows) and neurons (gray arrows), a low level of Chd8 expression is detected in few OPCs (PDGFRα+ cells, white arrowheads) but is hardly detectable in astrocytes (CC1low-expressing cells, gray arrowheads). (Scale bar, 20 μm.) (B) Immunofluorescence at P21 showing young mature MOG+ OLs still expressing Chd8 (white arrows). (B1) Detail of the Inset shown in B; gray arrows correspond to Chd8+ neurons. (Scale bar, 20 μm.) (C) Summary representation of Chd8 and Chd7 expression at different stages of the OL cell lineage, as identified by PDGFRα, CC1, and MOG expression. (D) Venn diagrams depicting the overlap of Chd7-, Chd8-, and Brg1-binding sites in OPCs. (E and F) Graph showing the number of correlations of Chd7 (blue), Chd8 (red), and Chd7-Chd8 (green) peaks in OPCs compared with the position in promoter regions (E) or enhancer regions (F). (G) Overlap of Chd7- and Chd8-bound genes in OPCs with examples of genes involved in OL cell differentiation (blue), cell death (orange), and cell cycle (red). (H) Overlap between ASD-risk genes and Chd7- and Chd8-bound genes in OPCs. (I) Representative ChIP-seq tracks for Chd8 and control IgG together with Olig2, Sox10, Chd7, and active epigenetic marks (H3K27ac and H3K4me3) in Olig2, Olig1, Sox10, Mog, and Cdk1 gene regions in OPCs.
Fig. 3. Chd8 binds together with Chd7 to OPC differentiation, proliferation, and survival genes. (A) Chd8 immunolabeling of P14 brain sections showing Chd8 expression in all maturing OLs (CC1high-expressing cells, arrows) of the CC, as well as in neurons of the cortex (Ctx). (A1) Detail of the Inset in A showing that, beside the high Chd8 expression in maturing OLs (white arrows) and neurons (gray arrows), a low level of Chd8 expression is detected in few OPCs (PDGFRα+ cells, white arrowheads) but is hardly detectable in astrocytes (CC1low-expressing cells, gray arrowheads). (Scale bar, 20 μm.) (B) Immunofluorescence at P21 showing young mature MOG+ OLs still expressing Chd8 (white arrows). (B1) Detail of the Inset shown in B; gray arrows correspond to Chd8+ neurons. (Scale bar, 20 μm.) (C) Summary representation of Chd8 and Chd7 expression at different stages of the OL cell lineage, as identified by PDGFRα, CC1, and MOG expression. (D) Venn diagrams depicting the overlap of Chd7-, Chd8-, and Brg1-binding sites in OPCs. (E and F) Graph showing the number of correlations of Chd7 (blue), Chd8 (red), and Chd7-Chd8 (green) peaks in OPCs compared with the position in promoter regions (E) or enhancer regions (F). (G) Overlap of Chd7- and Chd8-bound genes in OPCs with examples of genes involved in OL cell differentiation (blue), cell death (orange), and cell cycle (red). (H) Overlap between ASD-risk genes and Chd7- and Chd8-bound genes in OPCs. (I) Representative ChIP-seq tracks for Chd8 and control IgG together with Olig2, Sox10, Chd7, and active epigenetic marks (H3K27ac and H3K4me3) in Olig2, Olig1, Sox10, Mog, and Cdk1 gene regions in OPCs.CC BY-NC-ND · PubMed Central
Fig. 4. Chd7 LOF in OPCs does not affect cell proliferation. (A) Immunolabeling of PDGFRα+ cells in the CC and cortex (Ctx) of P7 Control (Ctrl) and Chd7iKO (iKO) mice. (Scale bars, 10 μm.) (B) Quantification of PDGFRα+ cells (nb/mm2) in the CC and Ctx of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 5). (C) Barplot representing the log fold-change (LogFC) of genes involved in cell cycle and proliferation between iKO and Ctrl mice. Dashed gray line represent FC = 1.2 (n = 7). (D) Immunostaining of MCM2 and PDGFRα in the CC from P7 Ctrl and iKO mice. (Scale bars, 10 μm.) (E) Quantification of the density of MCM2+ and MCM2− PDGFRα+-OPCs (nb/mm2) in the CC of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 3). (F) Quantification of MCM2+ cells as a percentage of total PDGFRα+ cells in the CC of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 3). Exact P values can be found in Dataset S2. *P < 0.05, **P < 0.01, and ***P < 0.001.
Fig. 4. Chd7 LOF in OPCs does not affect cell proliferation. (A) Immunolabeling of PDGFRα+ cells in the CC and cortex (Ctx) of P7 Control (Ctrl) and Chd7iKO (iKO) mice. (Scale bars, 10 μm.) (B) Quantification of PDGFRα+ cells (nb/mm2) in the CC and Ctx of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 5). (C) Barplot representing the log fold-change (LogFC) of genes involved in cell cycle and proliferation between iKO and Ctrl mice. Dashed gray line represent FC = 1.2 (n = 7). (D) Immunostaining of MCM2 and PDGFRα in the CC from P7 Ctrl and iKO mice. (Scale bars, 10 μm.) (E) Quantification of the density of MCM2+ and MCM2− PDGFRα+-OPCs (nb/mm2) in the CC of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 3). (F) Quantification of MCM2+ cells as a percentage of total PDGFRα+ cells in the CC of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 3). Exact P values can be found in Dataset S2. *P < 0.05, **P < 0.01, and ***P < 0.001.CC BY-NC-ND · PubMed Central
Fig. 5. Chd7 promotes OPC survival through p53 down-regulation. (A) Immunostaining of Casp3 and PDGFRα in the CC of P7 iKO mice. (Scale bar, 10 μm.) (B) Quantification of Casp3+ OPCs as a percentage of OPCs in P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 3 Ctrl and 4 iKO). (C) Barplot representing the LogFC of Trp53 and p53 target-genes involved in apoptosis pathway (red), cell-cycle arrest (orange), or DNA repair (yellow) between iKO and Ctrl mice. Dashed gray line represents FC = 1.2 (n = 7 Ctrl and 5 iKO). (D) Immunostaining of p53 and PDGFRα in the CC from P7 Ctrl and iKO mice. (Scale bars, 10 μm.) (E and F) Quantification of p53+ OPCs (nb/mm2, E) or as a percentage of OPCs (F) in the CC and Ctx of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 3 Ctrl and 4 iKO). (G) Quantification of MCM2+ and MCM2− cells as a percentage of total p53+ cells in the CC of iKO P7 mice. Data are presented as mean ± SEM (n = 3 Ctrl and 4 iKO). (H) Representative tracks for Trp53 locus integrating: (i) ChIP-seq data for Olig2 and Sox10, Chd7, and Chd8 in OPCs and; (ii) ATAC data from Ctrl and iKO P7 OPCs. (I, Left) Diagram representing tamoxifen (Tam) administration at P1 and P4 and PFT injection at P3, P4, and P5 followed by tissue collection at P7. (Right) Immunostaining of PDGFRα in the CC from P7 Ctrl, iKO and iKO+PFT mice. (Scale bars, 10 μm.) (J) Quantification of p53+ cells as a percentage of OPCs in the CC of P7 Ctrl, iKO, Ctrl+PFT, and iKO+PFT mice. Data are presented as mean ± SEM (n = 3 Ctrl, 4 iKO, 3 Ctrl+PFT and 3 iKO+PFT). (K) Quantification of PDGFRα+ cells (nb/mm2) in the CC of P7 Ctrl, iKO, Ctrl+PFT and iKO+PFT mice. Data are presented as mean ± SEM (n= 5 Ctrl, 5 iKO, 3 Ctrl+PFT and 3 iKO+PFT). (L) Quantification of MCM2+ cells as a percentage of OPCs in the CC of P7 Ctrl+PFT and iKO+PFT mice. Data are presented as mean ± SEM (n = 3). (M) Scheme representing Chd7 function in OPC survival. Proliferative OPCs (light blue), noncycling OPCs (blue) in Ctrl, iKO, and iKO+PFT mice. Exact P values can be found in Dataset S2. *P < 0.05, **P < 0.01, and ***P < 0.001.
Fig. 5. Chd7 promotes OPC survival through p53 down-regulation. (A) Immunostaining of Casp3 and PDGFRα in the CC of P7 iKO mice. (Scale bar, 10 μm.) (B) Quantification of Casp3+ OPCs as a percentage of OPCs in P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 3 Ctrl and 4 iKO). (C) Barplot representing the LogFC of Trp53 and p53 target-genes involved in apoptosis pathway (red), cell-cycle arrest (orange), or DNA repair (yellow) between iKO and Ctrl mice. Dashed gray line represents FC = 1.2 (n = 7 Ctrl and 5 iKO). (D) Immunostaining of p53 and PDGFRα in the CC from P7 Ctrl and iKO mice. (Scale bars, 10 μm.) (E and F) Quantification of p53+ OPCs (nb/mm2, E) or as a percentage of OPCs (F) in the CC and Ctx of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 3 Ctrl and 4 iKO). (G) Quantification of MCM2+ and MCM2− cells as a percentage of total p53+ cells in the CC of iKO P7 mice. Data are presented as mean ± SEM (n = 3 Ctrl and 4 iKO). (H) Representative tracks for Trp53 locus integrating: (i) ChIP-seq data for Olig2 and Sox10, Chd7, and Chd8 in OPCs and; (ii) ATAC data from Ctrl and iKO P7 OPCs. (I, Left) Diagram representing tamoxifen (Tam) administration at P1 and P4 and PFT injection at P3, P4, and P5 followed by tissue collection at P7. (Right) Immunostaining of PDGFRα in the CC from P7 Ctrl, iKO and iKO+PFT mice. (Scale bars, 10 μm.) (J) Quantification of p53+ cells as a percentage of OPCs in the CC of P7 Ctrl, iKO, Ctrl+PFT, and iKO+PFT mice. Data are presented as mean ± SEM (n = 3 Ctrl, 4 iKO, 3 Ctrl+PFT and 3 iKO+PFT). (K) Quantification of PDGFRα+ cells (nb/mm2) in the CC of P7 Ctrl, iKO, Ctrl+PFT and iKO+PFT mice. Data are presented as mean ± SEM (n= 5 Ctrl, 5 iKO, 3 Ctrl+PFT and 3 iKO+PFT). (L) Quantification of MCM2+ cells as a percentage of OPCs in the CC of P7 Ctrl+PFT and iKO+PFT mice. Data are presented as mean ± SEM (n = 3). (M) Scheme representing Chd7 function in OPC survival. Proliferative OPCs (light blue), noncycling OPCs (blue) in Ctrl, iKO, and iKO+PFT mice. Exact P values can be found in Dataset S2. *P < 0.05, **P < 0.01, and ***P < 0.001.CC BY-NC-ND · PubMed Central
Fig. 6. Chd7 promotes the expression of genes involved in OPC differentiation and maturation. (A) Barplot of the LogFC of genes involved in OPC differentiation, OL maturation, or coding for myelin proteins between P7Chd7iKO (iKO) and Ctrl. The dashed gray line represents fold-change = 1.2 (n = 7 Ctrl and 5 iKO). (B) Immunostaining of Itpr2 and APC together with Nkx2.2 and Olig1 in the CC from P7 control (Ctrl) and iKO (iKO) mice. (Scale bars, 10 μm.) (C) Quantification of Nkx2.2+, Itpr2+, and APC+ cells (nb/mm2) in the CC of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 4 Ctrl and 5 iKO). (D) Immunostaining of PDGFRα and Nkx2.2 in the CC from P7 Ctrl, iKO, and iKO+PFT mice. (Scale bars, 10 μm.) (E) Quantification of Nkx2.2+ cells (nb/mm2) in the CC of P7 Ctrl, iKO, Ctrl+PFT and iKO+PFT mice. Data are presented as mean ± SEM (n = 3 Ctrl, 5 iKO, 3 Ctrl+PFT and 3 iKO+PFT). (F) Summary representation of OL cell lineage progression in P7 iKO and iKO+PFT, mice. Circle size is proportional to the size of OL lineage cell-type population, as quantified in the CC. Dotted lines: OL population size in Ctrl. (G) Representative tracks for Olig1, Olig2, Gpr17, and Mbp locus integrating: (i) ChIP data for main oligodendroglial TFs (Olig2 and Sox10) and chromatin remodeling factors (Chd7, Chd8) in OPCs and; (ii) ATAC data from Ctrl and iKO P7 OPCs. Exact P values can be found in Dataset S2. *P < 0.05, **P < 0.01, and ***P < 0.001.
Fig. 6. Chd7 promotes the expression of genes involved in OPC differentiation and maturation. (A) Barplot of the LogFC of genes involved in OPC differentiation, OL maturation, or coding for myelin proteins between P7Chd7iKO (iKO) and Ctrl. The dashed gray line represents fold-change = 1.2 (n = 7 Ctrl and 5 iKO). (B) Immunostaining of Itpr2 and APC together with Nkx2.2 and Olig1 in the CC from P7 control (Ctrl) and iKO (iKO) mice. (Scale bars, 10 μm.) (C) Quantification of Nkx2.2+, Itpr2+, and APC+ cells (nb/mm2) in the CC of P7 Ctrl and iKO mice. Data are presented as mean ± SEM (n = 4 Ctrl and 5 iKO). (D) Immunostaining of PDGFRα and Nkx2.2 in the CC from P7 Ctrl, iKO, and iKO+PFT mice. (Scale bars, 10 μm.) (E) Quantification of Nkx2.2+ cells (nb/mm2) in the CC of P7 Ctrl, iKO, Ctrl+PFT and iKO+PFT mice. Data are presented as mean ± SEM (n = 3 Ctrl, 5 iKO, 3 Ctrl+PFT and 3 iKO+PFT). (F) Summary representation of OL cell lineage progression in P7 iKO and iKO+PFT, mice. Circle size is proportional to the size of OL lineage cell-type population, as quantified in the CC. Dotted lines: OL population size in Ctrl. (G) Representative tracks for Olig1, Olig2, Gpr17, and Mbp locus integrating: (i) ChIP data for main oligodendroglial TFs (Olig2 and Sox10) and chromatin remodeling factors (Chd7, Chd8) in OPCs and; (ii) ATAC data from Ctrl and iKO P7 OPCs. Exact P values can be found in Dataset S2. *P < 0.05, **P < 0.01, and ***P < 0.001.CC BY-NC-ND · PubMed Central
Fig. 7. OPC differentiation requires both Chd7 and Chd8 remodelers. (A) Diagram representing transduction protocol used on neural stem cells (NSCs) with a lentivirus-expressing Cre and a scramble shRNA or a shRNA against Chd8 and followed by fixation after 6 d of differentiation. (B) Immunostaining of Nkx2.2 and PDGFRα together with GFP in Ctrl (ROSA26Rstop-floxed-YFP +scramble), Chd8KD (ROSA26Rstop-floxed-YFP +Chd8 shRNA), Chd7cKO/+ (Chd7Flox/+;ROSA26Rstop-floxed-YFP +scramble), or Chd7cKO/+;Chd8KD (Chd7Flox/+;ROSA26Rstop-floxed-YFP +Chd8 shRNA) conditions. White arrowheads represent PDGFRα+-GFP+ OPCs and gray arrowheads represent Nkx2.2+-GFP+ iOLs. (Scale bars, 20 μm.) (C and D) Ratio between Nkx2.2+-GFP+ iOLs and PDGFRα+-GFP+ OPCs (C) and between Nkx2.2+-GFP− iOLs and PDGFRα+-GFP− OPCs (D) in Ctrl, Chd8KD, Chd7cKO/+, and Chd7cKO/+;Chd8KD conditions. Data are presented as mean ± SEM (n = 4). (E) Quantification of PDGFRα+-GFP+ cells as a percentage of total GFP+ cells in Ctrl, Chd8KD, Chd7cKO/+, and Chd7cKO/+;Chd8KD conditions. Data are presented as mean ± SEM (n = 3). (F) Quantification of cells (nb/mm2) in Ctrl, Chd8KD, Chd7cKO/+, and Chd7cKO/+;Chd8KD conditions. Data are presented as mean ± SEM (n = 3). Exact P values can be found in Dataset S2. *P < 0.05, **P < 0.01, and ***P < 0.001.
Fig. 7. OPC differentiation requires both Chd7 and Chd8 remodelers. (A) Diagram representing transduction protocol used on neural stem cells (NSCs) with a lentivirus-expressing Cre and a scramble shRNA or a shRNA against Chd8 and followed by fixation after 6 d of differentiation. (B) Immunostaining of Nkx2.2 and PDGFRα together with GFP in Ctrl (ROSA26Rstop-floxed-YFP +scramble), Chd8KD (ROSA26Rstop-floxed-YFP +Chd8 shRNA), Chd7cKO/+ (Chd7Flox/+;ROSA26Rstop-floxed-YFP +scramble), or Chd7cKO/+;Chd8KD (Chd7Flox/+;ROSA26Rstop-floxed-YFP +Chd8 shRNA) conditions. White arrowheads represent PDGFRα+-GFP+ OPCs and gray arrowheads represent Nkx2.2+-GFP+ iOLs. (Scale bars, 20 μm.) (C and D) Ratio between Nkx2.2+-GFP+ iOLs and PDGFRα+-GFP+ OPCs (C) and between Nkx2.2+-GFP− iOLs and PDGFRα+-GFP− OPCs (D) in Ctrl, Chd8KD, Chd7cKO/+, and Chd7cKO/+;Chd8KD conditions. Data are presented as mean ± SEM (n = 4). (E) Quantification of PDGFRα+-GFP+ cells as a percentage of total GFP+ cells in Ctrl, Chd8KD, Chd7cKO/+, and Chd7cKO/+;Chd8KD conditions. Data are presented as mean ± SEM (n = 3). (F) Quantification of cells (nb/mm2) in Ctrl, Chd8KD, Chd7cKO/+, and Chd7cKO/+;Chd8KD conditions. Data are presented as mean ± SEM (n = 3). Exact P values can be found in Dataset S2. *P < 0.05, **P < 0.01, and ***P < 0.001.CC BY-NC-ND · PubMed Central
Fig. 8. Chd7/Chd8 and Olig2/Sox10 bind to regulatory elements of active stage-specific genes in oligodendroglia. (A) Diagram representing a set of genes with timely controlled expression (data from ref. 35) divided in three groups: OPC genes (Ascl1 and Pdgfrα), iOL genes (Nkx2.2 and Gpr17), and mOL genes (Mbp and Omg). (B–G) Schematic representation from Genomatix genome browser of Ascl1 (B), Pdgfrα (C), Gpr17 (D), Nkx2.2 (E), Mbp (F), and Omg (G) locus integrating ChIP-seq data for main oligodendroglial TFs (Olig2 and Sox10), chromatin remodeling factors (Chd7, Chd8), and active epigenetic marks (H3K27ac and H3K4me3) in OPCs and OLs. (H) Synthesis representation of the dynamic cooperation between TFs (Sox10, Olig2) and chromatin remodelers (Chd7, Chd8) for the timely regulation of OPC- and OL-gene expression with genes not yet expressed (1), genes starting to express (2), expressed genes (3), and genes not expressed anymore (4).
Fig. 8. Chd7/Chd8 and Olig2/Sox10 bind to regulatory elements of active stage-specific genes in oligodendroglia. (A) Diagram representing a set of genes with timely controlled expression (data from ref. 35) divided in three groups: OPC genes (Ascl1 and Pdgfrα), iOL genes (Nkx2.2 and Gpr17), and mOL genes (Mbp and Omg). (B–G) Schematic representation from Genomatix genome browser of Ascl1 (B), Pdgfrα (C), Gpr17 (D), Nkx2.2 (E), Mbp (F), and Omg (G) locus integrating ChIP-seq data for main oligodendroglial TFs (Olig2 and Sox10), chromatin remodeling factors (Chd7, Chd8), and active epigenetic marks (H3K27ac and H3K4me3) in OPCs and OLs. (H) Synthesis representation of the dynamic cooperation between TFs (Sox10, Olig2) and chromatin remodelers (Chd7, Chd8) for the timely regulation of OPC- and OL-gene expression with genes not yet expressed (1), genes starting to express (2), expressed genes (3), and genes not expressed anymore (4).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 121

Metadata

Authors
Marie, C., Clavairoly, A., Frah, M., Hmidan, H., Yan, J., Zhao, C., Van Steenwinckel, J., Daveau, R., Zalc, B., Hassan, B., Thomas, J.-L., Gressens, P., Ravassard, P., Moszer, I., Martin, D. M., Lu, Q. R., & Parras, C.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Inserm (FR)
  • Cincinnati Children's Hospital Medical Center (US)
  • Promoting Research Oriented Towards Early CNS Therapy, INSERM, Université Paris Diderot, Sorbonne Paris Cité, F-75019 Paris, France;
  • University of Michigan (US)
Corresponding author
Parras, Carlos
Venue
Proceedings of the National Academy of Sciences
Published
2018-08-14
Volume
115
Issue
35
Pages
E8246-E8255
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2885048100
Cited by
103
References
51
Citations by year
2026: 7 · 2025: 8 · 2024: 6 · 2023: 12 · 2022: 9 · 2021: 33 · 2020: 16 · 2019: 11 · 2018: 1
FWCI
5.58
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by-nc-nd)
Funders
  • National Multiple Sclerosis Society (NMSS RG-1501-02851)
  • Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques (ARSEP grants 2014, 2015, 2017)
  • Fondation pour la Recherche Médicale (2017)
  • HHS | National Institutes of Health (R01NS072427 and R01NS075243, R01 DC009410 and R01 DC014456)
  • Agence Nationale de la Recherche (ANR-10- IAIHU-06 and ANR-11-INBS-0011-NeurATRIS)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
oligodendrocyte precursor cells, CHD7, CHD8, chromatin remodeling, apoptosis, p53, oligodendrocyte differentiation, myelination, CHARGE syndrome, autism spectrum disorder, gene repression, gene activation, oligodendroglia, brain development
MeSH terms
Autism Spectrum Disorder, Homeobox Protein Nkx-2.2, Animals, Cell Survival, DNA-Binding Proteins, Nuclear Proteins, Oligodendroglia, Stem Cells, Transcription Factors, Mice, Knockout, Homeodomain Proteins, Chromatin Assembly and Disassembly, Mice, CHARGE Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8. https://app.cochat.ai/papers/10.1073/pnas.1802620115
The paper
Marie, C., Clavairoly, A., Frah, M., Hmidan, H., Yan, J., Zhao, C., Van Steenwinckel, J., Daveau, R., Zalc, B., Hassan, B., Thomas, J.-L., Gressens, P., Ravassard, P., Moszer, I., Martin, D. M., Lu, Q. R., & Parras, C. (2018). Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1802620115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.